OpenSAFELY codelists
- Nebulised asthma and COPD medications dm+d
-
A list of nebulised medications preparations at VMP and AMP from the NHS Dictionary of Medicines and Devices that are used in asthma and COPD.
- Newer aminosalicylates for IBD BNF
- Newer aminosalicylates for IBD - dmd dm+d
-
dmd codelist for newer aminosalicylates for IBD; balsalazide, mesalazine, olsalazine.
- Nirmatrelvir drug interactions (consider risks and benefits) BNF
-
Drugs with a recommendation of 'consider risks and benefits' in the Specialist Pharmacy Services publication on interactions with the drug Nirmatrelvir, published 2022-02-02.
- Non-high dose long acting opioids (OpenPrescribing) - dm+d dm+d
-
dm+d version of non-high dose opioid codelist.
Taken from long-acting opioid denominator in OpenPrescribing, with a calculated Oral Morphine Equivalence of <120mg a day of a long acting regular opioid.
From OpenPrescribing: "The calculations are based on likely doses of long acting, regular opioids, for example morphine sulphate tablets or fentanyl patches. For example, we have assumed that MST 60mg tablets are “high dose”, as they are usually taken as one tablet twice daily (120mg daily dose), whereas MST 30mg are not, as the daily dose is 60mg. We have not included preparations used for breakthrough pain, e.g. Oramorph, or opioid injections which tend to be used more commonly in palliative care. "
- Non-high dose long acting opioids (OpenPrescribing) - Pseudo BNF BNF
-
Taken from long-acting opioid denominator in OpenPrescribing, with a calculated Oral Morphine Equivalence of <120mg a day of a long acting regular opioid.
From OpenPrescribing: "The calculations are based on likely doses of long acting, regular opioids, for example morphine sulphate tablets or fentanyl patches. For example, we have assumed that MST 60mg tablets are “high dose”, as they are usually taken as one tablet twice daily (120mg daily dose), whereas MST 30mg are not, as the daily dose is 60mg. We have not included preparations used for breakthrough pain, e.g. Oramorph, or opioid injections which tend to be used more commonly in palliative care. "
- Oestrogen and oestrogen-like drugs dm+d
-
This codelist contains codes for oestrogen and oestrogen-like drugs that potentially increase the risk of thrombotic events.
- OpenPrescribing Measure: Antibiotic stewardship: prescribing of trimethoprim vs nitrofurantoin (denominator) dm+d
-
Drugs used as the denominator of the following OpenPrescribing measures:
- OpenPrescribing Measure: Antibiotic stewardship: prescribing of trimethoprim vs nitrofurantoin (numerator) dm+d
-
Drugs used as the numerator of the following OpenPrescribing measures:
- OpenPrescribing Measure: Antibiotic stewardship: volume of antibiotic prescribing (numerator) dm+d
-
Antibacterial drugs contained with BNF section 5.1, as used by OpenPrescribing "Antibiotic stewardship: volume of antibiotic prescribing (KTT9)" measure.
- OpenPrescribing Measure: Co-amoxiclav, cephalosporins and quinolones (numerato dm+d
-
List of "broad-spectrum" antibiotics used by the following OpenPrescribing measures based on NICE guidance note KTT9:
- Opioid-containing medicines (buccal, nasal and oromucosal- excluding drugs for substance misuse) - Pseudo BNF BNF
-
All opioid-containing products which are given via buccal, nasal, or oromuscosal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
- Opioid-containing medicines (buccal, nasal and oromucosal- excluding drugs for substance misuse) - dm+d dm+d
-
All opioid-containing products which are given via buccal, nasal, or oromuscosal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
- Opioid-containing medicines (inhalation- excluding drugs for substance misuse) - Pseudo BNF BNF
-
All opioid-containing products which are given via inhaled route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
- Opioid-containing medicines (inhalation- excluding drugs for substance misuse) - dm+d dm+d
-
All opioid-containing products which are given via inhaled route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)